Nitric oxide synthase (EC 1.14.13.39) binds arginine and NADPH as subs
trates, and FAD, FMN, tetrahydrobiopterin, haem and calmodulin as cofa
ctors. The protein consists of a central calmodulin-binding sequence f
lanked on the N-terminal side by a haem-binding region, analogous to c
ytochrome P-450, and on the C-terminal side by a region homologous wit
h NADPH:cytochrome P-450 reductase. The structure of recombinant rat b
rain nitric oxide synthase was analysed by limited proteolyis. The pro
ducts were identified by using antibodies to defined sequences, and by
N-terminal sequencing. Low concentrations of trypsin produced three f
ragments, similar to those in a previous report [Sheta, McMillan and M
asters (1994) J. Biol. Chem. 269, 15147-15153]: that of M(r) approx. 1
35 000 (N-terminus Gly-221) resulted from loss of the N-terminal exten
sion (residues 1-220) unique to neuronal nitric oxide synthase. The fr
agments of M(r) 90 000 (haem region) and 80 000 (reductase region, N-t
erminus Ala-728) were produced by cleavage within the calmodulin-bindi
ng region. With more extensive trypsin treatment, these species were s
hown to be transient, and three smaller, highly stable fragments of M(
r) 14 000 (N-terminus Leu-744 within the calmodulin region), 60 000 (N
-terminus Gly-221) and 63 000 (N-terminus Lys-856 within the FMN domai
n) were formed. The species of M(r) approx. 60 000 represents a domain
retaining haem and nitroarginine binding. The two species of M(r) 63
000 and 14 000 remain associated as a complex. This complex retains cy
tochrome c reductase activity, and thus is the complete reductase regi
on, yet cleaved at Lys-856. This cleavage occurs within a sequence ins
ertion relative to the FMN domain present in inducible nitric oxide sy
nthase. Prolonged proteolysis treatment led to the production of a pro
tein of M(r) approx. 53 000 (N-terminus Ala-953), corresponding to a c
leavage between the FMN and FAD domains. The major products after chym
otryptic digestion were similar to those with trypsin, although the pa
thway of intermediates differed. The haem domain was smaller, starting
at residue 275, yet still retained the arginine binding site. These d
ata have allowed us to identify stable domains representing both the a
rginine/haem-binding and the reductase regions.